Fostering Knowledge Exchange in Online Communities: A Social Capital Building Approach

Prior studies on knowledge contribution started with the motivating role of social capital to predict knowledge contribution but did not specifically examine how they can be built in the first place. Our research addresses this gap by highlighting the role technology plays in supporting the development of social capital and eventual knowledge sharing intention. Herein, we propose four technology-based social capital builders – identity profiling, sub-community building, feedback mechanism, and regulatory practice – and theorize that individuals’ use of these IT artifacts determine the formation of social capital, which in turn, motivate knowledge contribution in online communities. Data collected from 253 online community users provide support for the proposed structural model. The results show that use of IT artifacts facilitates the formation of social capital (network ties, shared language, identification, trust in online community, and norms of cooperation) and their effects on knowledge contribution operate indirectly through social capital

System Development Service Quality: A Comparison of the In-House Development and the Application Outsourcing Environment

Very few studies have investigated the service quality of the system development process. In this study, an instrument based on SERVPERF\u27s service quality dimensions, i.e., tangibles, reliability, empathy, responsiveness, and assurance, was developed to study the service quality for in-house and outsourced system development process. Analysis of the data collected from 152 system users who had also involved in the development of those systems supported the validity and reliability of the newly developed measures. The relative contribution of the individual service quality dimensions to the overall system development service quality was found to vary between the outsourcing and in-house group, so as the impact of the overall system development service quality on the perceived usefulness and perceived ease of use. These results suggest that users may evaluate the services provided by outsourcing vendors and in-house IT personnel differently

Corporate E-banking: A Study based on DeLone and McLean’s IS Success Model

Although there are ample of studies dealing with retail internet banking, very few studies have investigated corporate internet banking. The objective of the current research is to study the determinants of the intention to continue use online banking of the existing corporate customers. This study collected data from 154 customers of an international bank to test a model developed from the DeLone and McLean’s IS success model. The results show that system quality contributes most to the perception of overall quality of the corporate e-banking service as well as the impact on the future use intention. Other factors that are found to be important are human service quality, information quality, and accuracy and security of the system

Building Trust in Online Shopping: The Moderating Effect of Individualism and Collectivism

As online shopping becoming more global, consumers with different culture had different consideration when shopping online. Thus, this study attempts to investigate how one specific dimension of culture, individualism-collectivism, moderates the relationship between online trust and its determinants The determinant factors under investigation include perceived risk, privacy, security, social exchange and information content. Data collected from customers of online shops from Hong Kong and Switzerland were used to test the research model. The result indicated that perceived risk had a negative relationship with Trust. Perceived risk had a stronger effect on trust for collectivists than individualists. Also, Security had a positive relationship with trust. The study showed that information content was positively related to trust of online vendors. Information content had a stronger effect on trust for individualists then collectivists

Effects Of Supply Chain Strategies And Practices On Firm Performance

A number of studies have looked at the impacts of supply chain strategies on firm performance. Yet, how different supply chain practices translate to firm performance remains unclear. Drawing from the resource based view, this study investigates the role of supply chain capabilities in mediating the relationships between supply chain practices and firm performance. A survey was conducted with 171 manufacturing firms in five Chinese cities to empirically validate the research model. Our findings suggest that, supply chain practices, as driven by supply chain strategies, create different supply chain capabilities and lead to firm performance. The findings shed some lights on the mechanism in which supply chain strategies and practices translate into firm performance

UNDERSTANDING THE DETERMINANTS OF BLOCKCHAIN ADOPTION IN SUPPLY CHAINS: AN EMPIRICAL STUDY IN CHINA

This study adopts affordance approach to understand how supply chain managers interpret the possible benefits that can be performed within blockchain-enabled supply chain applications. With a focus on governance efficiency improvement, the impacts of traceability and transparency affordance on uncertainty reduction were examined from the perspective of transaction cost theory in supply chain industry. Partial least squares – structural equation modelling (PLS-SEM) was used to analyze the data collected from 364 experienced supply chain managers in China. The results revealed that traceability affordance exerted significant impacts on environmental and trading partner uncertainty rather than transparency affordance, which in turn affected the adoption intention. This study contributes to the extant literature by embedding transaction cost in blockchain affordances. The findings are useful in guiding practitioners to improve blockchain system design for reducing uncertainties in supply chain environment, leading to a higher adoption rate of blockchain technology

Incident heart failure and myocardial infarction in sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitor users

Aims This study aimed to compare the rates of major cardiovascular adverse events in sodium-glucose cotransporter-2 inhibitors (SGLT2I) and dipeptidyl peptidase-4 inhibitors (DPP4I) users in a Chinese population. SGLT2I and DPP4I are increasingly prescribed for type 2 diabetes mellitus patients. However, few population-based studies are comparing their effects on incident heart failure or myocardial infarction. Methods and results This was a population-based retrospective cohort study using the electronic health record database in Hong Kong, including type 2 diabetes mellitus patients receiving either SGLT2I or DPP4I from 1 January 2015 to 31 December 2020. Propensity score matching was performed in a 1:1 ratio based on demographics, past comorbidities, and non-SGLT2I/DPP4I medications with nearest neighbour matching (caliper = 0.1). Univariable and multivariable Cox models were used to identify significant predictors for new-onset heart failure, new-onset myocardial infarction, cardiovascular mortality, and all-cause mortality. Sensitivity analyses with competing risk models and multiple propensity score matching approaches were conducted. A total of 41 994 patients (58.89% males, median admission age at 58 years old, interquartile range [IQR]: 51.2–65.3) were included with a median follow-up of 5.6 years (IQR: 5.32–5.82). In the matched cohort, SGLT2I use was significantly associated with lower risks of new-onset heart failure (hazard ratio [HR]: 0.73, 95% confidence interval [CI]: [0.66, 0.81], P < 0.0001), myocardial infarction (HR: 0.81, 95% CI: [0.73, 0.90], P < 0.0001), cardiovascular mortality (HR: 0.67, 95% CI: [0.53, 0.84], P < 0.001), and all-cause mortality (HR: 0.26, 95% CI: [0.24, 0.29], P < 0.0001) after adjusting for significant demographics, past comorbidities, and non-SGLT2I/DPP4I medications. Conclusions SGLT2 inhibitors are protective against adverse cardiovascular events including new-onset heart failure, myocardial infarction, cardiovascular mortality, and all-cause mortality. The prescription of SGLT2I is preferred when taken into consideration individual cardiovascular and metabolic risk profiles in addition to drug–drug interactions

Comparison of sodium-glucose cotransporter-2 inhibitor and dipeptidyl peptidase-4 inhibitor on the risks of new-onset atrial fibrillation, stroke and mortality in diabetic patients: A propensitysScore-matched study in Hong Kong

Objective To compare the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2Is) and dipeptidyl peptidase-4 inhibitors (DPP4Is) on adverse outcomes in diabetic patients in Hong Kong. Methods This was a retrospective population-based cohort study of type 2 diabetes mellitus patients (n = 72,746) treated with SGLT2I or DPP4I between January 1, 2015, and December 31, 2020, in Hong Kong. Patients with exposure to both DPP4I and SGLT2I therapy, without complete demographics or mortality data, or who had prior atrial fibrillation (AF) were excluded. The study outcomes were new-onset AF, stroke/transient ischemic attack, cardiovascular mortality and all-cause mortality. Propensity score matching (1:1 ratio) between SGLT2I and DPP4I users was performed. Results The unmatched study cohort included 21,713 SGLT2I users and 39,510 DPP4I users (total: n = 61,233 patients; 55.37% males, median age: 62.7 years [interquartile range (IQR): 54.6–71.9 years]). Over a median follow-up of 2030 (IQR: 1912–2117) days, 2496 patients (incidence rate [IR]: 4.07%) developed new-onset AF, 2179 patients (IR: 3.55%) developed stroke/transient ischemic attack, 1963 (IR: 3.20%) died from cardiovascular causes and 6607 patients (IR: 10.79%) suffered from all-cause mortality. After propensity score matching (SGLT2I: n = 21,713; DPP4I: n = 21,713), SGLT2I users showed lower incidence of new-onset AF (1.96% vs. 2.78%, standardized mean difference [SMD] = 0.05), stroke (1.80% vs. 3.52%, SMD = 0.11), cardiovascular mortality (0.47% vs. 1.56%, SMD = 0.11) and all-cause mortality (2.59% vs. 7.47%, SMD = 0.22) compared to DPP4I users. Cox regression found that SGLT2I users showed lower risk of new-onset AF (hazard ratio [HR]: 0.68, 95% confidence interval [CI]: [0.56, 0.83], P = 0.0001), stroke (HR: 0.64, 95% CI: [0.53, 0.79], P < 0.0001), cardiovascular mortality (HR: 0.39, 95% CI: [0.27, 0.56], P < 0.0001) and all-cause mortality (HR: 0.44, 95% CI: [0.37, 0.51], P < 0.0001) after adjusting for significant demographics, past comorbidities, medications and laboratory tests. Conclusions Based on real-world data of type 2 diabetic patients in Hong Kong, SGLT2I use was associated with lower risk of incident AF, stroke/transient ischemic attack, and cardiovascular and all-cause mortality outcomes compared to DPP4I use